These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 31259714

  • 1. The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ.
    Wang X, Huang S, Xin X, Ren Y, Weng G, Wang P.
    Acta Pharm; 2019 Mar 01; 69(1):111-119. PubMed ID: 31259714
    [Abstract] [Full Text] [Related]

  • 2. Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells.
    Xie W, Wang L, Sheng H, Qiu J, Zhang D, Zhang L, Yang F, Tang D, Zhang K.
    Med Sci Monit; 2017 Jan 03; 23():29-37. PubMed ID: 28045889
    [Abstract] [Full Text] [Related]

  • 3. Telmisartan-Induced Cytotoxicity via G2/M Phase Arrest in Renal Cell Carcinoma Cell Lines.
    Tsujiya Y, Hasegawa A, Yamamori M, Okamura N.
    Biol Pharm Bull; 2021 Jan 03; 44(12):1878-1885. PubMed ID: 34853271
    [Abstract] [Full Text] [Related]

  • 4. Umbelliferone arrest cell cycle at G0/G1 phase and induces apoptosis in human oral carcinoma (KB) cells possibly via oxidative DNA damage.
    Vijayalakshmi A, Sindhu G.
    Biomed Pharmacother; 2017 Aug 03; 92():661-671. PubMed ID: 28586740
    [Abstract] [Full Text] [Related]

  • 5. Umbelliferone exhibits anticancer activity via the induction of apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells.
    Yu SM, Hu DH, Zhang JJ.
    Mol Med Rep; 2015 Sep 03; 12(3):3869-3873. PubMed ID: 25997538
    [Abstract] [Full Text] [Related]

  • 6. Dauricine inhibits viability and induces cell cycle arrest and apoptosis via inhibiting the PI3K/Akt signaling pathway in renal cell carcinoma cells.
    Zhang S, Ren Y, Qiu J.
    Mol Med Rep; 2018 May 03; 17(5):7403-7408. PubMed ID: 29568902
    [Abstract] [Full Text] [Related]

  • 7. Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cells.
    Hsieh YH, Lee CH, Chen HY, Hsieh SC, Lin CL, Tsai JP.
    Tumour Biol; 2015 Sep 03; 36(10):7539-47. PubMed ID: 25916210
    [Abstract] [Full Text] [Related]

  • 8. In vitro anticancer activities of osthole against renal cell carcinoma cells.
    Liu L, Mao J, Wang Q, Zhang Z, Wu G, Tang Q, Zhao B, Li L, Li Q.
    Biomed Pharmacother; 2017 Oct 03; 94():1020-1027. PubMed ID: 28810525
    [Abstract] [Full Text] [Related]

  • 9. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
    Xu B, Deng Y, Bi R, Guo H, Shu C, Shah NK, Chang J, Liu G, Du Y, Wei W, Wang C.
    Cancer Chemother Pharmacol; 2018 Jun 03; 81(6):1083-1093. PubMed ID: 29667067
    [Abstract] [Full Text] [Related]

  • 10. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE, Song HJ, Lim S, Lee SJ, Lim JE, Nam DH, Joo KM, Jeong BC, Jeon SS, Choi HY, Lee HW.
    Oncotarget; 2015 Oct 20; 6(32):33046-64. PubMed ID: 26426994
    [Abstract] [Full Text] [Related]

  • 11. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L, Wang Q, Mao J, Qin T, Sun Y, Yang J, Han Y, Li L, Li Q.
    Chem Biol Interact; 2018 Dec 25; 296():145-153. PubMed ID: 30273566
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells.
    Huang S, Tuergong G, Zhu H, Wang X, Weng G, Ren Y.
    Acta Pharm; 2021 Jun 01; 71(2):267-278. PubMed ID: 33151174
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase.
    Wang LS, Chen SJ, Zhang JF, Liu MN, Zheng JH, Yao XD.
    BMC Urol; 2017 May 30; 17(1):38. PubMed ID: 28558682
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
    Kim EA, Kim SW, Nam J, Sung EG, Song IH, Kim JY, Kwon TK, Lee TJ.
    Oncotarget; 2016 May 31; 7(22):31832-46. PubMed ID: 27092874
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.